TY - JOUR
T1 - Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression
AU - Pratiwi, Rarastoeti
AU - Fletcher, Linda M.
AU - Pyper, Wendy R.
AU - Do, Kim Anh
AU - Crawford, Darrell H.G.
AU - Powell, Lawrie W.
AU - Jazwinska, Elizabeth C.
N1 - Funding Information:
This study was supported by the National Health and Medical Research Council of Australia. RP is a recipient of the UNESCO/TWAS Fellowship Program in the Human Genome and Center Grant Project, IUC-Biotechnology, Gadjah Mada University, Indonesia.
PY - 1999/7
Y1 - 1999/7
N2 - Background/Aims: Hereditary haemochromatosis shows a wide variation in phenotypic expression, which is thought to be due, in part, to genetic factors. A single missense mutation in HFE, leading to an amino acid substitution (C282Y) has been shown to be the causative mutation, clearly responsible for clinical expression of the disorder. Since homozygosity for the C282Y mutation can give rise to a disorder which shows wide variation in clinical expression, we investigated the possibility that genetic modifiers of HFE may exist. Methods: Linkage disequilibrium analysis was performed on chromosome 6p21.3 in 74 patients homozygous for the C282Y mutation using microsatellite markers spanning the haemochromatosis gene region. Phenotypic expression was evaluated based on transferrin saturation, serum ferritin, hepatic iron concentration and index, and iron grade. Results: Linkage disequilibrium (LD) analysis showed a predominant ancestral haplotype from D6S265 to D6S2236 covering a region of approximately 5 Mb. The overall LD distribution in this region showed two peaks of highly significant association at D6S105 (2 Mb proximal to HFE) and at D6S2239 approximately 50 kb distal to HFE. Male patients homozygous for D6S105 allele 8, had significantly higher hepatic iron indices than patients heterozygous or nullizygous for D6S105-8 (p<0.038). Conclusion: This analysis indicates that modifying gene(s) or another mutation affecting HHC clinical expression may be located in the region of D6S105.
AB - Background/Aims: Hereditary haemochromatosis shows a wide variation in phenotypic expression, which is thought to be due, in part, to genetic factors. A single missense mutation in HFE, leading to an amino acid substitution (C282Y) has been shown to be the causative mutation, clearly responsible for clinical expression of the disorder. Since homozygosity for the C282Y mutation can give rise to a disorder which shows wide variation in clinical expression, we investigated the possibility that genetic modifiers of HFE may exist. Methods: Linkage disequilibrium analysis was performed on chromosome 6p21.3 in 74 patients homozygous for the C282Y mutation using microsatellite markers spanning the haemochromatosis gene region. Phenotypic expression was evaluated based on transferrin saturation, serum ferritin, hepatic iron concentration and index, and iron grade. Results: Linkage disequilibrium (LD) analysis showed a predominant ancestral haplotype from D6S265 to D6S2236 covering a region of approximately 5 Mb. The overall LD distribution in this region showed two peaks of highly significant association at D6S105 (2 Mb proximal to HFE) and at D6S2239 approximately 50 kb distal to HFE. Male patients homozygous for D6S105 allele 8, had significantly higher hepatic iron indices than patients heterozygous or nullizygous for D6S105-8 (p<0.038). Conclusion: This analysis indicates that modifying gene(s) or another mutation affecting HHC clinical expression may be located in the region of D6S105.
KW - HHC clinical expression
KW - Iron overload
KW - Modifying genes
UR - http://www.scopus.com/inward/record.url?scp=0032992157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032992157&partnerID=8YFLogxK
U2 - 10.1016/S0168-8278(99)80161-5
DO - 10.1016/S0168-8278(99)80161-5
M3 - Article
C2 - 10424281
AN - SCOPUS:0032992157
SN - 0168-8278
VL - 31
SP - 39
EP - 46
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 1
ER -